Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serum protein corona components refer to the complex and dynamic assembly of proteins, lipids, and other biomolecules that spontaneously adsorb onto the surface of nanoparticles upon exposure to biological fluids like blood or serum (Monopoli et al., 2012, Nature Nanotechnology). This phenomenon is characterized by a 'hard corona' of high-affinity, slowly exchanging proteins and a 'soft corona' of low-affinity, rapidly exchanging proteins (Walkey & Chan, 2012, Chemical Society Reviews). The corona effectively masks the nanoparticle's synthetic surface properties, providing it with a 'biological identity' that dictates its physiological fate, including biodistribution, toxicity, and cellular internalization (Corbo et al., 2016, Nanomedicine). While not a single therapeutic target, the corona is a critical factor in nanomedicine design, as specific components like opsonins can trigger immune clearance, while others like apolipoproteins can facilitate crossing the blood-brain barrier (Borgognoni et al., 2019, Nanoscale). Understanding and manipulating the corona is essential for improving the efficacy and safety of nanoparticle-based drug delivery systems.
The protein corona defines the biological identity of nanoparticles; it interacts with cell surface receptors (e.g., scavenger receptors, LDL receptors) to mediate endocytosis or triggers the mononuclear phagocyte system for clearance.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serum protein corona components (PC).